No Data
Earnings Preview: Clarus to Report Financial Results Post-market on March 06
Clarus Announces Bob Krause as New Chief Financial Officer
Clarus Keeps Their Buy Rating on Data Commun Management (DCM)
Clarus Sets Fourth Quarter and Full Year 2024 Conference Call for Thursday, March 6, 2025, at 5:00 P.m. ET
Clarus Corporation's (NASDAQ:CLAR) Intrinsic Value Is Potentially 93% Above Its Share Price
Testosterone Replacement Therapy Market Forecast Report 2025-2033, With Key Player Profiles for AbbVie, Clarus Therapeutics, Ferring Pharmaceuticals, Lupin, Pfizer, Teva Pharmaceuticals and More
Press Release: Roger Werner Appointed to Clarus' Board of Directors
